Hoth Therapeutics Inc (NASDAQ:HOTH) traded at $1.35 at close of the session on Tuesday, March 19, made an upward move of 17.39% on its previous day’s price.
Looking at the stock we see that its previous close was $1.15 and the beta (5Y monthly) reads 0.59 . In terms of its 52-week price range, HOTH has a high of $4.30 and a low of $0.99. The company’s stock has lost about -2.17% over that past 30 days.
Hoth Therapeutics Inc has a market cap of $5.87 million and is expected to release its quarterly earnings report on Mar 31, 2024 – Apr 04, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.51, with the EPS growth for the year raised at -$2.5 for 2023 and -$1.89 for next year. These figures represent 73.70% and 24.40% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the HOTH stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is 6.42% off its SMA20 and 2.74% from its 50-day simple moving average. The RSI (14) is pointing at 56.00 while the volatility over the past week is 13.13% and jumps to 7.29% over the past one month. The beta value is 0.59, while the average true range (ATR) is currently pointing at 0.11.
Coming back to Hoth Therapeutics Inc (NASDAQ:HOTH), we note that the average 3-month trading volume was 222.91K, while that of the preceding 10-day period stands at 24270.0. Current shares outstanding are 4.35 million.
The insiders hold 0.93% of the company’s shares while institutions hold 7.07%. The data shows that short shares as of Feb 29, 2024, stood at 76360.0 at a short ratio of 1.82. This represents a 1.76% short interest in shares outstanding on Feb 29, 2024. Shares short fall in February from the previous month at 0.11 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -6.25% down in year-to-date price movement.
